Viseven

JANUARY 13, 2023

Creating Health Outcomes Guide The entirety of the field data collected by HEORs as well as analytical reports may provide valuable data for Health Outcomes Guide. If you are looking for a professional channel for all pharmaceutical and life science-related topics, get in touch with the experts at Viseven by filling contact form below.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Documentation 40

PharmaShots

MARCH 6, 2023

Using analytics and machine learning throughout the drug discovery, development, and innovation processes maximizes the value of data for patient outcomes. Clinical trials are a key topic for these interactions. Recruitment of patients into clinical trials is an ongoing challenge for all clinical studies.

Immunization 40

Immunization Pharmaceutical Companies Pharmaceutical Companies Hospitals 40

European Pharmaceutical Review

FEBRUARY 23, 2023

Given the widely reported challenges of validation and qualification of microbiological methods, as well as lab compliance and keeping up with compendial amendments, I have steered away from these topics here. It is often used for sample handling, dilution, analysis and evaluation.

Dosage 94

Dosage Vaccines 94

ISPE

MAY 25, 2023

™ is the concept of ‘Plug and Produce’ connectivity, with a dedicated team on this topic led by Wolfgang Winter, and this part of the session will go on to provide practical insights on Pharma 4.0™ ISPE members can join the ongoing PAT journey in the ISPE Engage forum Process Analytical Control & Lifecycle Strategy. The Pharma 4.0™

FDA 96

FDA 96

Pharmaceutical Technology

MAY 10, 2023

Particle analysis on a micro-scale is a significant topic in several fields of application. Even a single particle can be enough for chemical analysis, unlike with many other common analytical techniques, which require more sample material. This enables faster imaging speeds by increasing device sensitivity.

52

52

Roots Analysis

SEPTEMBER 20, 2023

However, owing to the increased legalization for the use of medical cannabis, a number of players offering cannabis testing services, robust instrumentation, software and consumables have entered this domain over the years. You can also download the SAMPLE REPORT on this topic by Roots Analysis by clicking on the link Cannabis Testing Market.

Compounding 40

Compounding Labelling 40

ISPE

JULY 7, 2023

The BCM processes discussed during the workshop used various inline analytics for monitoring certain conditions and integrated control modules to maintain control over their process. Daniel Some from Wyatt Technology presented their ultra-DAWN real-time light-scattering instrument for inline monitoring and real-time release of product.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

SEPTEMBER 11, 2023

Emerging Technologies and Recent Applications Agility, flexibility, and reproducibility of a biomanufacturing operating model are enabled and empowered by a variety of advanced technologies including, but not limited to, single-use technology (SUT), process analytical technology (PAT), continuous manufacturing (CM), POD, and Pharma 4.0™

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

NOVEMBER 30, 2022

Moreover, prescriptive analytics enable the user to understand how a piece of equipment will fail, providing information on the most significant contributing factors. iSpeak Blog posts provide an opportunity for the dissemination of ideas and opinions on topics impacting the pharmaceutical industry. Register Now.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

AUGUST 29, 2022

Following approval of an initial marketing application, postapproval changes are needed to ensure adequate supply, mitigate supply risk, expand patient market access, optimize manufacturing processes, improve analytical methods, and comply with new regulatory expectations. risk mitigation of critical reagents/instruments).

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

MARCH 15, 2023

Statutory Instruments. Yet, as potential environmental sustainability solutions are identified, one should consider any tradeoffs or synergies to other systems or categories and prioritize the comprehensive, net results. Following inspiration from such initiatives as PAT and Pharma 5.0, August 2018. www.iso.org/standard/69426.html

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52